Titlebook: Cancer Nanotheranostics; Volume 1 Muthupandian Saravanan,Hamed Barabadi Book 2021 The Editor(s) (if applicable) and The Author(s), under ex

團(tuán)結(jié)

Emerging Protein and Peptide-Based Nanomaterials for Cancer Therapeutics,dicine. In comparison to metallic or inorganic nanoparticles, the protein- or peptide-based nanocarriers/nano-delivery systems are advantageous as they do not pose potential adverse health effects. Besides, protein- and peptide-based nanocarriers are inexpensive and easy to synthesize in lab setting

牛的細(xì)微差別

Emerging Polymer-Based Nanomaterials for Cancer Therapeutics,ul treatment. Nanomaterials have revolutionized the current delivery of cancer therapy and diagnosis. To overcome the drawbacks of conventional cancer treatment, it is necessary to smartly design and tailor-make nanomaterials which precisely recognize and deliver the drug payload at the targeted sit

FLASK

Emerging Metal-Organic Framework Nanomaterials for Cancer Theranostics,r exceptional characteristics including ultrahigh surface area/porosity, tunable particle/pore size, versatile structures/morphologies, as well as biocompatibility. The combination of all these features together has made them desirable for many applications..Their unique physicochemical properties a